Company Monitoring Page for Vivus

latest headlines for company on cafepharma

An 80% Plunge Leads the Biotech Bloodbath
Motley Fool
Tue, 09/25/12 - 12:41 pm
Tags:
Peregrine Pharmaceuticals, Vertex Pharmaceuticals, Questcor, Arena Pharmaceuticals, Vivus
Obesity In America Likely To Set Up Arena And Vivus For Big Gains
TheStreet.com
Tue, 09/25/12 - 12:37 pm
Tags:
Arena Pharmaceuticals, Vivus, obesity, Qsymia, Belviq
In The Wake Of An FDA Probe, It's Time Questcor Shareholders Begin To Consider Alternatives
Seeking Alpha
Mon, 09/24/12 - 06:03 pm
Tags:
FDA, Questcor, Arena Pharmaceuticals, Merck, Pfizer, Vivus, Athcar
Vivus Plunges on European Setback; Analysts React
Barron's
Sat, 09/22/12 - 02:18 pm
Tags:
Vivus, Qsymia
EU Approval? Fat Chance!
Motley Fool
Sat, 09/22/12 - 02:15 pm
Tags:
Vivus, obesity, weight loss, Qsymia
Vivus Shares Feel The Pain: Blockbuster Diet Drug Likely Won't Be Sold In Europe
Forbes
Fri, 09/21/12 - 01:00 pm
Tags:
Vivus, Europe, Qsiva, Qsymia, obesity
2 Big Events For Obesity Drugmakers
Motley Fool
Thu, 09/20/12 - 11:10 am
Tags:
obesity, Arena Pharmaceuticals, Vivus, Qsymia, Belviq
[video] Fatter Profits for Drug Makers Ahead?
CNBC
Tue, 09/18/12 - 04:43 pm
Tags:
obesity, Arena Pharmaceuticals, Orexigen, Vivus
Vivus Launches Qsymia - What To Look For Now
Seeking Alpha
Tue, 09/18/12 - 11:28 am
Tags:
Vivus, Qsymia, Arena Pharmaceuticals, Eisai
Vivus Quietly Notes In 8-k That Qsymia Is Now Commercially Available
Yahoo/Reuters
Mon, 09/17/12 - 10:13 am
Tags:
Qsymia, obesity, Vivus, Topiramate, J&J
Another Weight Loss Drug Gets Props from Wall Street
Wall Street Cheat Street
Sun, 09/9/12 - 11:04 am
Tags:
Orexigen, Vivus, Arena Pharmaceuticals, Contrave, Belviq, Qsymia, weight loss, obesity
Vivus, Arena: Don't Be Too Late To The Punch Bowl, Buy Other Stocks
Seeking Alpha
Sat, 09/8/12 - 10:55 am
Tags:
Vivus, Arena Pharmaceuticals, Pfizer, Neuralstem, Geron
Vivus' 60 Critical Minutes That Could Double Qsymia's Addressable Market
Seeking Alpha
Sat, 09/8/12 - 10:38 am
Tags:
Vivus, Qsymia, weight loss, obesity
Arena And Vivus Set To Dominate The Obesity Drug Market
Seeking Alpha
Thu, 08/30/12 - 09:58 am
Tags:
Arena, Vivus, obesity, Belviq, Qsymia
3 Reasons to Sell: VIVUS
Motley Fool
Thu, 08/23/12 - 09:54 am
Tags:
Vivus, patents, Qsymia
Now That Vivus Was Downgraded, Where Should Investors Turn?
Seeking Alpha
Mon, 08/20/12 - 11:45 am
Tags:
Vivus, investors, obesity, Qsymia
3 Drug Companies That Want to Lose
Motley Fool
Sun, 08/19/12 - 11:32 am
Tags:
Arena, Vivus, Orexigen, obesity, weight loss, Belviq, Qsymia, Contrave, Empatic
Healthcare Biz Recap: Vivus’ PATENT Problem, Idenix Survives Clinical HOLD
Wall Street Cheat Street
Sat, 08/18/12 - 03:48 pm
Tags:
Vivus, generics, Qsymia, Idenix, Pluristem Therapeutics
Vivus Falls after Downgrade
Barron's
Sat, 08/18/12 - 03:33 pm
Tags:
Vivus, Qsymia, generics
Vivus Bulls: A Chance To Get In At $15.80 Or Earn An Extra 18.8%
Seeking Alpha
Sat, 08/18/12 - 03:32 pm
Tags:
Vivus

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.